Rossignol Sylvie, Netchine Irène, Le Bouc Yves, Gicquel Christine
Explorations fonctionnelles endocriniennes, Hôpital Trousseau (APHP); INSERM U515; Université Pierre et Marie Curie-Paris6, 26 avenue du Dr Netter, 75012 Paris, France.
Best Pract Res Clin Endocrinol Metab. 2008 Jun;22(3):403-14. doi: 10.1016/j.beem.2008.01.012.
Silver-Russell syndrome (SRS) is a clinically heterogeneous syndrome characterized by intra-uterine and postnatal growth retardation with spared cranial growth, dysmorphic features and frequent body asymmetry. Various cytogenetic abnormalities have been described in a small number of SRS or SRS-like cases involving chromosomes 7, 8, 11, 15, 17 and 18. However, until recent data became available involving imprinted genes on chromosome 7 and chromosome 11p15, the molecular cause of the syndrome was unknown in most cases. Genomic imprinting is the best example of transcriptional control of genes by epigenetic modifications. Many imprinted genes play key roles in fetal and placental growth and behaviour. This is illustrated in SRS, which can now be considered as a new imprinting disease model. These new findings in the pathophysiology of SRS allow long-term follow-up studies to be performed based on molecular diagnosis. This could help to define appropriate clinical guidelines regarding growth and feeding difficulties.
Silver-Russell综合征(SRS)是一种临床异质性综合征,其特征为宫内和出生后生长迟缓,颅骨生长正常,存在畸形特征且身体经常不对称。在少数涉及7号、8号、11号、15号、17号和18号染色体的SRS或SRS样病例中,已描述了各种细胞遗传学异常。然而,直到最近有涉及7号染色体和11号染色体p15区域印记基因的数据可用之前,该综合征在大多数情况下的分子病因尚不清楚。基因组印记是通过表观遗传修饰对基因进行转录控制的最佳范例。许多印记基因在胎儿和胎盘的生长及行为中起关键作用。这在SRS中得到了体现,现在SRS可被视为一种新的印记疾病模型。SRS病理生理学的这些新发现使得能够基于分子诊断进行长期随访研究。这有助于制定关于生长和喂养困难的适当临床指南。